featured
SGLT-2i and AF in the CV and Renal Outcome Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT-2i and Atrial Fibrillation in the Cardiovascular and Renal Outcome Trials
Diabetes Obes Metab 2020 Oct 01;[EPub Ahead of Print], V Okunrintemi, BM Mishriky, JR Powell, DM CummingsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.